Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer [Phase 4]
Phase 4 trial comparing trabectedin plus pegylated liposomal doxorubicin versus platinum-based therapy in platinum-sensitive recurrent ovari…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery [NA]
This completed clinical trial compared a single-dose tranexamic acid with placebo in ovarian cancer surgery to assess perioperative blood lo…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors [Phase 1, Phase 2]
Valerio Therapeutics terminated a Phase 1/2 trial of VIO-01 in patients with advanced or metastatic solid tumors, including breast, ovarian,…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery [Phase 4]
This Phase 4 clinical trial update describes using near-infrared fluorescence imaging with indocyanine green to evaluate bowel anastomoses i…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update of atezolizumab, guadecitabine, and CDX-1401 vaccine in recurrent platinum-resistant ovarian, fallopian tube, and prim…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Spatial Radiogenomics of Ovarian Cancer
A clinical trial titled Spatial Radiogenomics of Ovarian Cancer (NCT06324175) is currently recruiting, sponsored by Fondazione Policlinico U…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer [Phase 4]
A Phase IV multicenter trial of olaparib in Indian patients with ovarian cancer and metastatic breast cancer has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: BP1001-A in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
This clinical trial update states that BP1001-A is being evaluated in a Phase 1 study for advanced or recurrent solid tumors and is currentl…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating tazemetostat for recurrent ovarian or endometrial cancers; the study is currently not recruiting…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
A completed multicancer registry study (PREFER) assessing the prevalence of actionable biomarkers and driver mutations across advanced cance…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2, Phase 3]
This clinical trial update reports results from a Phase 2/3 study evaluating pegylated liposomal doxorubicin in combination with atezolizuma…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Study of AK112 in the Treatment of Advanced Gynecological Tumors [Phase 2]
Phase 2 study of AK112 for advanced gynecologic tumors has been completed, evaluating efficacy in ovarian, cervical, and endometrial cancers…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients [Phase 2]
A Phase 2 trial evaluating Fluzoparib in combination with Apatinib versus Fluzoparib alone in relapsed ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours [Phase 1]
Phase 1 first-in-human study to evaluate safety, tolerability and antineoplastic activity of OATD-02 in patients with selected advanced/meta…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer [Phase 1]
Phase 1 study evaluating intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in untreated ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating heated intraperitoneal chemotherapy with doxorubicin and cisplatin for pediatric abdominal/pelvic tu…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluates the combination of mirvetuximab soravtansine and rucaparib camsylate in patients with recurrent gynecologic cancer…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab [Phase 3]
A Phase III trial (ATALANTE) evaluated atezolizumab versus placebo in late-relapse ovarian cancer patients treated with chemotherapy plus be…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Phase 1 Dose Escalation of ArtemiCoffee [Phase 1]
Phase 1 dose-escalation trial of ArtemiCoffee in ovarian cancer has completed; this document provides an update on the study's status.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of SGN-ALPV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-ALPV in advanced solid tumors has been terminated; the trial evaluated multiple cancers including ovarian, end…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Study of SGN-STNV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-STNV in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) [NA]
Completed feasibility testing of the Informed Symptom Management System (PRISMS) for collecting patient-reported outcomes in cancer patients…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of SL-172154 (SIRPα-Fc-CD40L) in ovarian, fallopian tube, and primary peritoneal cancers has completed enrollment and posted r…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The Impact of the Inflammation Index on Predicting Postoperative Complications in Ovarian Cancer
A completed clinical trial evaluating whether the inflammation index can predict postoperative complications in ovarian cancer patients. The…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Abdominopelvic Cancer Prehabilitation [NA]
This clinical trial update reports completion of an abdominopelvic cancer prehabilitation study sponsored by Universitat Jaume I, involving …